Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial
about
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experimentSeek, test, treat: substance-using women in the HIV treatment cascade in South Africa.Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.ARV-based HIV prevention for women - where we are in 2014.Effectiveness and safety of oral HIV preexposure prophylaxis for all populationsPregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trialRethinking HIV prevention to prepare for oral PrEP implementation for young African womenPre-exposure prophylaxis in Southern Africa: feasible or not?Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalisPrEP as Peri-conception HIV Prevention for Women and Men.The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.The Potential of Pre-Exposure Prophylaxis for Women in Violent RelationshipsHIV pre-exposure prophylaxis for women.Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.A Review of HIV Pre-Exposure Prophylaxis: The Female PerspectiveSafety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Attitudes Toward HIV Pre-Exposure Prophylaxis in a United States Urban Clinic Population.Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States.Current and future contraceptive options for women living with HIV.Reproductive health counseling delivered to women living with HIV in the United States.Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion.Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelinesPrEP Implementation Science: State-of-the-Art and Research Agenda.Women and ARV-based prevention: opportunities and challenges.Alcohol use, expectancies and HIV-related sexual risk: a cross-sectional survey of male migrant workers in South India.Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs.Maximizing the Benefits of HIV Preexposure Prophylaxis.'These are not luxuries, it is essential for access to life': Disability related out-of-pocket costs as a driver of economic vulnerability in South Africa.Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.Empowering With PrEP (E-PrEP), a Peer-Led Social Media-Based Intervention to Facilitate HIV Preexposure Prophylaxis Adoption Among Young Black and Latinx Gay and Bisexual Men: Protocol for a Cluster Randomized Controlled TrialScale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya
P2860
Q28391248-559B33DB-9D01-4739-A556-4208C5C50B96Q28596813-8A23B93C-CF3F-4FEB-927C-E770E73EC28FQ33604304-FD054145-9F4E-4CD6-9FF4-45AF6C431988Q34034418-7A2C7AC0-7B01-459D-AE7A-7AE8EADC55A0Q34180729-0EF308B0-388B-456D-A077-AB82047B9065Q34677217-88376F4D-93FD-432B-AD18-CA9FD5DAF7C8Q35184560-7B1E6B6A-6AEF-4931-8AFA-8491F2E62D28Q35875710-81A8CBD1-BE42-42E5-8E3D-8FA532EB54C4Q35875719-86D68367-E9F0-4984-9190-0BA4ADF1E2ECQ36443803-467AA972-030A-4CAC-B914-1217CFDD7C80Q36619611-8A0FFBD6-5CB0-4F9C-83D3-7BE3D14ED225Q36816612-42979C7B-C052-4DAD-B1E1-DD3DC8E3D108Q36963511-59877FCD-8B02-4100-9C18-6D86686F63DAQ36988613-BF2009D9-1E12-42FE-8530-2710F5FCA8AAQ37019969-DFE565B5-9A6E-4882-BA23-23EDDE3104A6Q37141403-E1EF3490-10B4-4C03-86F7-24073F416DBBQ38667599-62FEED70-D176-405A-AE86-4AB308893109Q38672579-1ED56465-54B6-46FC-9832-0B814E0B8F67Q38750453-88251522-9FF4-44FE-97B6-A83EC3DEE209Q38851830-FAC72581-3E0C-4364-8F16-D0B693C1986BQ39108779-FCA765C7-EF2E-46C7-9341-E9EA483F2E06Q39821223-235F9EF5-F273-45E4-BCDF-A89690095E73Q39825094-DC401474-5CE9-46B7-8D3D-17D90BCF58D6Q40048203-FA24FE5C-581E-4FE6-BBC3-70DFA3482F24Q40361492-C5455EC7-A931-448A-810F-501F55ECE1D6Q40461101-98AF1243-C208-40A0-8C0E-502E4AB0DDD7Q42334798-591C549C-8915-4263-A760-DDB38EDCF4C9Q43241737-F522D4BE-252B-4ADB-8DC9-A61CA16740E7Q46553256-AFC03F1C-0A11-45D2-A3D8-7412B38B7A6BQ46817029-791480E9-E29C-4DCE-A22B-B757313428D8Q48537541-4F12DC1B-59D0-47C5-A297-1EEFF715743CQ52566642-28F82D25-25A8-403A-9A9C-8059795BF2BDQ52568614-72BC951F-3E20-43FC-9C62-511E07C6A2D7Q52571189-7B1981BB-BA38-4B35-81EC-95399B231020Q52685409-6EC3162C-38A4-4163-AF1B-ED54E19E122DQ57613806-B8BBF264-9EAD-4F33-B901-FB750DF4EF67Q58765180-5C238DEB-601C-498E-A7C3-3A00636A1872
P2860
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of preexposure prophy ...... alyses from a randomized trial
@en
Efficacy of preexposure prophy ...... lyses from a randomized trial.
@nl
type
label
Efficacy of preexposure prophy ...... alyses from a randomized trial
@en
Efficacy of preexposure prophy ...... lyses from a randomized trial.
@nl
prefLabel
Efficacy of preexposure prophy ...... alyses from a randomized trial
@en
Efficacy of preexposure prophy ...... lyses from a randomized trial.
@nl
P2093
P2860
P50
P1433
P1476
Efficacy of preexposure prophy ...... alyses from a randomized trial
@en
P2093
Andrew Mujugira
Erin M Kahle
James D Campbell
Jared M Baeten
Katherine K Thomas
Nelly Mugo
Pamela M Murnane
Partners PrEP Study Team
P2860
P304
P356
10.1097/QAD.0B013E3283629037
P407
P577
2013-08-01T00:00:00Z